<DOC>
	<DOC>NCT01202084</DOC>
	<brief_summary>The primary objective will be to compare the impact of the study formulations on pulmonary function in persistent asthma carriers.</brief_summary>
	<brief_title>A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Sign the ICF Age ≥ 12 years Persistent asthma diagnosis, as per the GINA classification (www.ginasthma.com),18 with symptoms for at least 6 months and clinically stable for at least 1 month, with the ACQ745 test (see Appendix C) ≤ 3.0 Current use of inhaled corticosteroid (beclomethasone dipropionate dose of up to 1000 µg), associated or not with longterm β2adrenergic agents and breakthrough medication (salbutamol or equivalent) Initial FEV1 of at least 40% of the predicted normal value Serum cortisol assessment within normal values. Use of oral or parenteral corticosteroid within the 3 months prior to study beginning Requirement of admission due to asthma within the 3 months prior to study beginning Presence of active smoking, defined as the use of cigarette, pipe, cigar or any form of smoking at any amount within the last 3 months Presence of severe comorbidities, such as cardiovascular, renal, liver, neurological, neoplastic, hematological, infectious, dermatological, neurological, psychiatric or chronic respiratory disease other than asthma Recent (&lt; 6 months) or predicted participation during this study in other clinical studies involving drugs of any nature or in studies of any form of intervention for treating asthma Intolerance or allergy to any of the components of the drugs assessed in the study Pregnancy or lactation Chronic use of βblocker medications, per routine oral or intravenous route, or also as ophthalmic solutions</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>